tbuckley/cabot-search huggingface dataset:
FRI-391 Relapse incidence and severe flares in chronic hepatitis B patients with lymphoma post rituximab-based chemotherapy versus HBeAg-negative hepatitis B patients without cancer after nucleos (t)ide analogue cessation
Authors: Yen-Chun Liu, Yu-Jia Shih, Rachel Wen-Juei Jeng, Chao-Wei Hsu, Rong-Nan Chien
Journal: Journal of Hepatology (2024)
SAT-381 Low diversity of the TCRbeta repertoire in patients with chronic hepatitis D
Authors: Maria Francesca Cortese, Adriana Palom, Beatriz Pacín Ruiz, Francesc Rudilla, Emma Enrich Randé, Mireia Antón Iborra, Juan Carlos Ruiz-Cobo, Mar Riveiro Barciela, David Tabernero, Ariadna Rando-Segura, Maria José Herrero, Maria Buti
Journal: Journal of Hepatology (2024)
WED-160 Autoantibody diagnostics in pediatric non-viral liver diseases: a multicenter retrospective head-to-head comparison of immunofluorescence- and enzyme-linked immunosorbent assay-based testing
Authors: Theresa Kirchner, Alejandro Campos-Murguia, Norman Junge, Muhammed Yuksel, Wojciech Janczyk, Claudine Lalanne, Kalliopi Zachou, Ye Htun Oo, Jérôme Gournay, Simon Pape, Joost PH Drenth, Amédée Renand, George Dalekos, Luigi Muratori, Piotr Socha, Cigdem Arıkan, Yun Ma, Heiner Wedemeyer, Ulrich Baumann, Bastian Engel, Richard Taubert
Journal: Journal of Hepatology (2024)
TOP-357 Second generation HBV siRNAs with novel chemistries demonstrate improved profiles compared with ALG-125755 and other clinical stage siRNAs
Authors: Jin Hong, Vivek Rajwanshi, Saul Montero, Min Luo, Kellan Passow, Cheng Liu, Hyunsoon Kang, Jacquelyn Sousa, Dana Cho, John Cortez, Shane Daguison, Kusum Gupta, Hua Tan, Vera Huang, Dawei Cai, Rostom Ahmed-Belkacem, Lawrence Blatt, David Smith, Leonid Beigelman, Julian Symons
Journal: Journal of Hepatology (2024)
FRI-430 Efficacy and safety of Tenofovir Amibufenamide in the treatment of chronic hepatitis B: a real-world multicenter clinical study
Authors: Yaping Li, Hongmei Zu, Yongmei Lin, Guoe Gou, Xiaohong Gao, Guang-Hua Xu, Dandan Cui, Shuangsuo Dang
Journal: Journal of Hepatology (2024)
TOP-359-YI Development of a replication-competent Vesicular Stomatitis Virus (VSV) vector for therapeutic hepatitis B vaccination
Authors: Jinpeng Su, Anna D. Kosinska, Susanne Miko, Edanur Ates-Öz, Dorothee von Laer, Janine Kimpel, Ulrike Protzer
Journal: Journal of Hepatology (2024)
SAT-379 Immune checkpoint proteins are associated with persistently elevated liver stiffness after successful HCV therapy in people with HIV
Authors: Rubén Martín-Escolano, Ana Virseda-Berdices, Juan Berenguer, Juan Gonzalez, Oscar Brochado-Kith, Amanda Fernández Rodríguez, Cristina Diez, Victor Hontañón, Salvador Resino Garcia, María Ángeles Jiménez Sousa
Journal: Journal of Hepatology (2024)
WED-435 Prevalence of active hepatitis delta infection among new diagnoses of hepatitis B in the Barcelona metropolitan area
Authors: Jesús Trejo Zahinos, Francisco Rodríguez-Frías, Marcos Belsol, Susana Bernalte, Ricard Riel, Camila Picchio, Maria Francesca Cortese, David Tabernero, Maria Buti, Ariadna Rando-Segura
Journal: Journal of Hepatology (2024)
TOP-369 HEV replication and genomic diversification in the human kidney
Authors: André Gömer, Avista Wahid, Lucas Hueffner, Martina Friesland, Katja Dinkelborg, Elmira Aliabadi, Fenja Laue, Saskia Janshoff, Markus Cornberg, Benjamin Maasoumy, Sven Pischke, Tobias Müller, Birgit Bremer, Julian Schulze zur Wiesch, Julia Benckert, Rainer Ulrich, Svenja Hardtke, Petra Dörge, Florian Vondran, Ansgar Lohse, Michael P. Manns, Daniel Todt, Heiner Wedemeyer, Thomas Pietschmann, Eike Steinmann, Patrick Behrendt
Journal: Journal of Hepatology (2024)
WED-164 Interim safety results of the ongoing international phase I/II GATEWAY gene therapy trial with VTX-801 conducted in adult patients with Wilson disease
Authors: Thomas Damgaard Sandahl, William M. Lee, Aftab Ala, Regino P. Gonzalez-Peralta, Valentina Medici, Fred Askari, Sean Rudnick, Ulrich Lauer, Hartmut Schmidt, Sonia Valero, Gloria Gonzalez, Jean Philippe Combal, Lorenzo D'Antiga, Bernard Benichou, Michael Schilsky
Journal: Journal of Hepatology (2024)
FRI-152-YI Gene editing to treat liver metabolic disorders: harnessing paired Cas9-Nickases for efficient and safe treatment of primary hyperoxaluria type 1
Authors: Laura Torella, Martin Bilbao-Arribas, Julia Klermund, Geoffroy Andrieux, África Vales Aranguren, Cristina Olague Micheltorena, Julen Torrens-Baile, Eduardo Salido, Toni Cathomen, Nerea Zabaleta, Gloria González-Aseguinolaza
Journal: Journal of Hepatology (2024)
WED-438-YI Real-world based cost effectiveness analysis of entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy
Authors: Chun-Ting Ho, Chien-Wei Su, Elise Chia-Hui Tan, Yi-Hsiang Huang, Ming-Chih Hou, Jaw-Ching Wu
Journal: Journal of Hepatology (2024)
SAT-377 CRISPR-Cas13b-mediated suppression of hepatitis B surface antigen-pre-clinical investigations of a new therapeutic approach
Authors: Laura McCoullough, Mohamed Fareh, Wenxin Hu, Vitina Sozzi, Christina Makhlouf, Yianni Droungas, Chee Leng Lee, Hans Netter, Mina Takawy, Sharon Lewin, Damian Purcell, Jacinta Holmes, Joseph Trapani, Margaret Littlejohn, Peter Revill
Journal: Journal of Hepatology (2024)
WED-513 Automatic opportunistic age screening for hepatitis C virus. A public health strategy in Galicia, Spain. Project 2023
Authors: Elena Cruz-Ferro, Susana Miras-Carballal, Marta Piñeiro-Sotelo, Sonia Touceda-Taboada, Ignacio Díaz-Vázquez, Javier Cereijo-Fernández, Juan Turnes Vazquez
Journal: Journal of Hepatology (2024)
Efficacy of Faricimab versus Aflibercept in Diabetic Macular Edema in the 20/50 or Worse Vision Subgroup in Phase III YOSEMITE and RHINE Trials
Authors: Marco Zarbin, David Tabano, Ayesha Ahmed, Manuel Amador, Allan Ding, Nancy Holekamp, Xiao-Yu Lu, Ivaylo Stoilov, Ming Yang
Journal: Ophthalmology (2024)

Diabetic Retinopathy Clinical Research Network Protocol T suggests that the response to treatment among patients with diabetic macular edema (DME) may vary depending on baseline best-corrected visual acuity (BCVA). We evaluated the efficacy of faricimab 6 mg versus aflibercept 2 mg over 2 years in patients with DME and baseline BCVA of 20/50 or worse enrolled in faricimab phase III trials.
WED-474 Population-based hepatitis C screening in Lithuania: 18-month results of the program and scenarios for achieving WHO elimination targets
Authors: Limas Kupcinskas, Egle Ciupkeviciene, Alexis Voeller, Viaceslavas Zaksas, Ligita Jancoriene, Edita Kazenaite, Viktorija Basyte-Basevice, Devin Razavi-Shearer, John Ward, Gediminas Urbonas, Janina Petkeviciene
Journal: Journal of Hepatology (2024)
WED-161-YI Liver steatosis and fibrosis in children with diabetes mellitus type 1: single-center analysis including MASLD-associated genetic variants
Authors: Jolanta Świderska, Wiktor Smyk, Sebastian Więckowski, Susanne N. Weber, Piotr Milkiewicz, Elżbieta Moszczyńska, Piotr Socha, Marcin Krawczyk
Journal: Journal of Hepatology (2024)
TOP-142-YI Safety and efficacy of direct oral anticoagulants in cirrhotic and non-cirrhotic splanchnic vein thrombosis
Authors: Lucia Giuli, Rosa Talerico, Silvia Betti, Francesca Bartolomei, Elena Rossi, Antonio Gasbarrini, Maurizio Pompili, Valerio De Stefano, Roberto Pola, Maria Pallozzi, Brigida Eleonora Annicchiarico, Francesca Romana Ponziani, Francesco Santopaolo
Journal: Journal of Hepatology (2024)
WED-477-YI Semi-quantitative interviews with chronic hepatitis B patients to determine their knowledge of hepatitis B, personal experiences and views on decentralisation of care in London, United Kingdom
Authors: Alexander Cole, Thi Thuan Nguyen, Yusuke Shimakawa, Ameet Dhar, Belinda Smith, Shevanthi Nayagam, Ashley Brown, Koen Peteers, Maud Lemoine
Journal: Journal of Hepatology (2024)
TOP-139 Combination of liver steatosis and premenopausal is a risk factor for DILI due to cyclin-dependent kinase 4/6 inhibitors as first-line treatment for metastatic breast cancer
Authors: Kreina Sharela Vega-Cano, Lourdes Ruiz-Ortega, Pau Mascaró Baselga, Paula Esteban, Oriol Mirallas Viñas, Francesca Filippi-Arriaga, Laia Joval Ramentol, Juan Carlos Ruiz-Cobo, Pau Benito Buch, Jesus Yaringaño, Gaspar Joaquin Molina, Diego Gomez Puerto, Lucia Sanz Gómez, Esther Zamora Adelantado, Maria Buti, Meritxell Bellet Ezquerra, Mar Riveiro Barciela
Journal: Journal of Hepatology (2024)
WED-439 Linkage of anti‐HCV reactive persons to HCV care and treatment services in Georgia
Authors: Vladimer Getia, Rania Tohme, Sophia Surguladze, Shaun Shadaker, Maia Tsereteli, Ekaterine Adamia, Amiran Gamkrelidze, Irina Tskhomelidze
Journal: Journal of Hepatology (2024)
WED-493-YI Direct-acting antivirals in women of reproductive age infected with hepatitis C virus
Authors: Krystyna Dobrowolska, Małgorzata Pawłowska, Dorota Zarębska-Michaluk, Piotr Rzymski, Ewa Janczewska, Magdalena Tudrujek-Zdunek, Hanna Berak, Włodzimierz Mazur, Jakub Klapaczynski, Beata Lorenc, Justyna Janocha-Litwin, Anna Parfieniuk-Kowerda, Dorota Dybowska, Piekarska Anna, Rafal Krygier, Beata Dobracka, Jerzy Jaroszewicz, Robert Flisiak
Journal: Journal of Hepatology (2024)
FRI-267 Regional fibrosis progression analysed by digital pathology with artificial intelligence is associated with renal dysfunction
Authors: Dan-Qin Sun, Jia-Qi Shen, Xiao-Fei Tong, Yangyang Li, Giovanni Targher, Yayun Ren, Haiyang Yuan, Chris D. Byrne, Hong You, Ming-Hua Zheng
Journal: Journal of Hepatology (2024)
Biological and psychosocial evidence in the Cass Review: a critical commentary
Authors: D. M. Grijseels
Journal: International Journal of Transgender Health (2024)

Background In 2020, the UK's National Health Services (NHS) commissioned an independent review to provide recommendations for the appropriate treatment for trans children and young people in its children's gender services. This review, named the Cass Review, was published in 2024 and aimed to provide such recommendations based on, among other sources, the current available literature and an independent research program.
FRI-010 A non-invasive predictive model based on CT radiomics for hepatic venous pressure gradient in liver cirrhosis
Authors: Xu Guo, Wuque Cai, Huan Tong, Tingrui Han, Jiayi He, Hongze Sun, Guiying Zhang, Xin Quan, Shuaijie Qian, Ying Li, Bo Wei, Yang Tai, Daqing Guo, Hao Wu
Journal: Journal of Hepatology (2024)
WED-259 Metabolic dysfunction-associated steatotic liver disease prevalence and predictors in patients with type 2 diabetes in primary care
Authors: Wile Balkhed, Patrik Nasr, Shan Cai, Christian Simonsson, Mikael Forsgren, Martin Bergram, Olof Dahlqvist Leinhard, Nils Dahlström, Carl-Johan Carlhäll, Peter Lundberg, Karin Rådholm, Fredrik Iredahl, Stergios Kechagias, Mattias Ekstedt
Journal: Journal of Hepatology (2024)
THU-232 Additive hepatoprotective effects of DA-1241, a novel GPR119 agonist, in combination with semaglutide in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
Authors: Monika Lewinska, Malte H. Nielsen, Susanne Pors, Henrik B. Hansen, Il Hoon Jung, Hyung Heon Kim, Michael Feigh, Mi-Kyung Kim
Journal: Journal of Hepatology (2024)
FRI-250 An intergenerational study of the prevalence and cardiometabolic significance of steatotic liver disease in adults in the Raine Study
Authors: Oyekoya Ayonrinde, Leon Adams, Trevor Mori, Phillip Melton, John Olynyk, Marilyn Zelesco, Andrea Mould, James Fiori, Lawrence Beilin, Girish Dwivedi, Frank Sanfilippo, Christopher Welman
Journal: Journal of Hepatology (2024)
WED-422 Screening for viral hepatitis in the emergency department-the methodology to automate a feasible, acceptable and effective solution
Authors: Julia Di Girolamo, David Prince, Basheer Alshiwanna, Robert Porritt, David Thomas, Shahida Bakridi, Hung Tran, Sophie Gryllis, Maria Tiglao, Rebecca Haack, Kristian Peralta, Melissa Bagatella, Irena Petrovski, Julie Doan, Richard Cracknell, Jeremy Lawrence, Michael Maley, Hong Foo, Nathan Jones, Gregory Dore, Miriam Levy
Journal: Journal of Hepatology (2024)
WED-306-YI Prevalence of metabolic-dysfunction associated steatotic liver disease among diabetic and non-diabetic patients in a dutch cohort: evaluation of hepatic steatosis and fibrosis using Fibroscan™
Authors: Alina Saidi, Willy Theel, Vivian de Jong, Diederick Grobbee, Femme Dirksmeier-Harinck, Manuel Castro Cabezas
Journal: Journal of Hepatology (2024)
WED-221 A novel point-of-care prediction model for steatotic liver disease: based on bioimpedance analysis
Authors: Jeayeon Park, Goh Eun Chung, Yoosoo Chang, Seungho Ryu, Yunmi Ko, Youngsu Park, Hyunjae Shin, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Won Sohn, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Journal: Journal of Hepatology (2024)
FRI-035 Development of a non-invasive machine learning-based model for predicting hepatic steatosis in patients with chronic hepatitis B
Authors: Zhiyi Zhang, Li Zhu, Yiguang Li, Jian Wang, Shaoqiu Zhang, Fei Cao, Juan Xia, Renling Yao, Xingxiang Liu, Jie Li, Chuanwu Zhu, Yuanwang Qiu, Rui Huang, CHao Wu
Journal: Journal of Hepatology (2024)
SAT-219 Discovering 1-piperidine propionic acid inhibiting effect on protease activated receptor 2 and serpinb3 as a new therapeutic strategy for metabolic dysfunction-associated steatohepatitis
Authors: Monica Chinellato, Gianmarco Villano, Erica Novo, Cristian Turato, Santina Quarta, Mariagrazia Ruvoletto, Alessandra Biasiolo, Andrea Martini, Stefania Cannito, Camilla Mazzucco, Matteo Gasparotto, Francesco Filippini, Luca Spiezia, Laura Cendron, Maria Guido, Roberto Vettor, Maurizio Parola, Patrizia Pontisso
Journal: Journal of Hepatology (2024)
THU-261 Artificial intelligence models deployed at scale on hematoxylin and eosin-stained whole slide images reveal stage-dependent collagen composition in metabolic dysfunction-associated steatohepatitis
Authors: Ylaine Gerardin, Neel Patel, Lara Murray, Adam Stanford-Moore, Jacqueline Brosnan-Cashman, Jun Xu, Lisa Boyette, Benjamin Glass, Timothy R. Watkins, Andrew N. Billin, Robert Egger
Journal: Journal of Hepatology (2024)
THU-227 Macrophage phenotype is affected by longitudinal treatment with Zalfermin in a model of metabolic dysfunction-associated steatohepatitis
Authors: Benedicte Kapel, Dora Hancz, Cesar Medina, Maria Dermit, Lise Flyger Walther Jensen, Sanne Skovgård Veidal, Jenny Egecioglu Norlin, Anouk Oldenburger, Birgitte Andersen, Dominik Pfister
Journal: Journal of Hepatology (2024)
WED-287 Sequential approach using combination of newly developed HOMA2-IR-ALT-TE-MASH (HALT-M) score and magnetic resonance elastography for non-invasive identifying at-risk metabolic dysfunction-associated steatohepatitis in obese subjects
Authors: Seung Kak Shin, Yoonseok Lee, Oh Sang Kwon, Yun Soo Kim, Ju Hyun Kim, Dae Ho Lee
Journal: Journal of Hepatology (2024)
WED-250-YI PNPLA3 I148M a useful diagnostic marker for significant fibrosis metabolic dysfunction-associated steatotic liver disease
Authors: Elias Rashu, Mikkel Werge, Mira Thing, Liv Hetland, Puria Nabilou, Nina Kimer, Anne-Sofie Houlberg Jensen, Anders Junker, Stefan Stender, Lise Lotte Gluud
Journal: Journal of Hepatology (2024)
FRI-235 Causes of death, mortality rates, and the role of sociodemographic risk factors and biomarkers in metabolic dysfunction-associated steatohepatitis mortality in more than 18, 000 real world patients from the United States
Authors: Jörn M Schattenberg, Claudio Sartini, Ronald Herrera, Mireia Raluy, Mark Yates, Ramy Younes
Journal: Journal of Hepatology (2024)
FRI-033 Enhancing MRCP precision: a comprehensive analysis of intramuscular glucagon administration impact on biliary visualization
Authors: Fadi Abu Baker, Oren Shibolet, Mohamad Garra, Randa Taher, Amani Beshara, Saif Abu Mouch, Michael Oster, Abdel-Rauf Zeina
Journal: Journal of Hepatology (2024)
WED-305 Comparison of two non-invasive models for advanced fibrosis (AF) detection in patients with type 2 diabetes (T2D) and MASLD using LiverSTAT, FIB-4 and liver stiffness measurement (LSM) with transient elastography (TE)
Authors: Mona Ismail, Abdulrahman Alabdulgader, Abdulnaser Barmou, Mona Munteanu
Journal: Journal of Hepatology (2024)
THU-020-YI Evolution of health-related quality of life in liver transplantation patients in relation to acceptance and metabolic liver disease
Authors: Janne Suykens, Louis Onghena, Frederik Berrevoet, Hans Van Vlierberghe, Xavier Verhelst, Sarah Raevens, Eric Hoste, Sander Lefere, Anja Geerts, Carine Poppe
Journal: Journal of Hepatology (2024)
THU-459-YI Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma: a multicentric retrospective study
Authors: Clémentine Alitti, Agnès Rode, Hervé Trillaud, Philippe Merle, Jean-Frédéric Blanc, Lorraine Blaise, Alix Demory, NKontchou Gisèle, Véronique Grando Lemaire, Marianne Ziol, Pierre Nahon, Nathalie Ganne-Carrié, Arthur Petit, Olivier Seror, Olivier Sutter, Jean Charles Nault
Journal: Journal of Hepatology (2024)
THU-248 Unraveling the interplay of FGF21 and GLP1 analogue in metabolic dysfunction-associated steatohepatitis in vivo
Authors: Anouk Oldenburger, Birgitte Björkenberg, Henning Hvid, Matthew Gillum, Dominik Pfister, Sanne Skovgård Veidal, Birgitte Andersen
Journal: Journal of Hepatology (2024)
THU-473 Complications of transarterial chemoembolization for hepatocellular carcinoma- 10 years’ experience of a tertiary center
Authors: Laura Iliescu, Simona Ioanitescu, Razvan Rababoc, Andreea Simu, Mihai Toma, Radu Dumitru, Cristian Mugur Grasu
Journal: Journal of Hepatology (2024)
THU-244 Synergistic hepatoprotective effects of semaglutide and resmetirom combination therapy in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
Authors: Kristoffer Voldum-Clausen, Jenny Egecioglu Norlin, Sanne Skovgård Veidal, Denise Oró, Line Nilsson, Henrik B. Hansen, Michael Feigh
Journal: Journal of Hepatology (2024)
WED-235 Prediction of metabolic dysfunction-associated steatohepatitis resolution
Authors: Rohit Loomba, Maral Amangurbanova, Ricki Bettencourt, Egbert Madamba, Harris Siddiqi, Lisa Richards, Mildred D. Gottwald, Shibao Feng, Maya Margalit, Daniel Huang
Journal: Journal of Hepatology (2024)
TOP-241-YI Longitudinal changes in liver stiffness measurements in a population-based screening cohort of 5, 517 participants
Authors: Katrine Tholstrup Bech, Jesse Pustjens, Robert J. de Knegt, Guillem Pera, Laurens van Kleef, Helle Lindholm Schnefeld, Peter Andersen, Johanne Kragh Hansen, Katrine Lindvig, Ruth Nadal, Marta Carol, Anna Soria, Elisa Pose, Adrià Juanola, Anita Arslanow, Núria Fabrellas, Miquel Serra, Ivica Grgurevic, Llorenç Caballeria, Salvatore Piano, Matthias Reichert, Rosa M Morillas, Juan Manuel Pericàs, Jörn M Schattenberg, Emmanuel Tsochatzis, Neil Guha, Pere Torán, Céline Fournier-Poizat, Anne Llorca, Laurent Castera, Frank Lammert, Isabel Graupera, Aleksander Krag, Willem Pieter Brouwer, Pere Ginès, Maja Thiele
Journal: Journal of Hepatology (2024)
WED-330 Description of a cohort of patients with metabolic dysfunction-associated steatotic liver disease followed at an urban liver centre (Toronto liver centre), high prevalence of extrahepatic conditions
Authors: Elizaveta Shpilevaia, Jason Xu, Josh Rais, Eva Pavic, Eva Fragoso, Farah Imdad Ali, Mehrdad Modarresi, Aleena Ghafoor, Anish Jammu, Marzena Magnes, Magdy Elkhashab
Journal: Journal of Hepatology (2024)
SAT-459 Assessments of health utilities in patients with metabolic dysfunction-associated steatohepatitis (MASH): cross-walk between CLDQ-NASH, SF-6D, and the EuroQol EQ-5D
Authors: Zobair Younossi, Maria Stepanova, Jesse Fishman, James Dodge, Dominic Labriola, Rebecca Taub, Fatema Nader
Journal: Journal of Hepatology (2024)
SAT-207 Safety and efficacy outcomes of endoscopic sleeve gastroplasty and lifestyle intervention in post-orthotopic liver transplant patients: A single-center, prospective pilot study
Authors: Jaclyn Tuck, David M.H. Chascsa, Blanca Lizaola-Mayo, Justin Potter, Alexis Baughman, Brian Arizmendi, Jaxon Quillen, Katie Kunze, Abraham Neena, Rahul Pannala
Journal: Journal of Hepatology (2024)
SAT-454-YI Non-housing related socioeconomic factors increase risk of liver fibrosis in screening of an urban population with steatotic liver disease
Authors: Huw Purssell, Stephanie Landi, Lucy Bennett, Oliver Street, Jennifer Scott, Christopher Mysko, Neil Guha, Karen Piper Hanley, Neil Hanley, Varinder Athwal
Journal: Journal of Hepatology (2024)
SAT-202 TERN-501, a highly selective thyroid hormone receptor β agonist, significantly improved MRI-PDFF, cT1, and liver volume in clinically relevant patient populations with presumed MASH: subgroup analyses from a 12-week phase 2a trial
Authors: Stephen A. Harrison, Naim Alkhouri, Mazen Noureddin, Eric Lawitz, Kris V. Kowdley, Rohit Loomba, Lois Lee, Christopher Jones, Erin Quirk
Journal: Journal of Hepatology (2024)
SAT-431-YI Exploring liver vitamin A status and histopathological associations in a Guatemalan cohort: insights into prolonged consumption of vitamin A fortified sugar
Authors: Giorgio Cazzaniga, Eric Boy, Anthony Oxley, Francisco Chew, Keyla Castellanos, Roberto Orozco, Zarina Guzmàn, Augusto Rodas, Elmar Gonzalèz, Georg Lietz, Dina Tiniakos
Journal: Journal of Hepatology (2024)
FRI-236-YI Racial disparities in incidence of cirrhosis and extrahepatic manifestations in metabolic dysfunction-associated steatotic liver disease
Authors: Majd Aboona, Leith Ghani, Pooja Rangan, Vincent Chen, Cheng Han Ng, Daniel Huang, Mark Muthiah, Donghee Kim, Moises Nevah Rubin, Ma Ai Thanda Han, Michael Fallon, Karn Wijarnpreecha
Journal: Journal of Hepatology (2024)
FRI-029 Shear wave elastography predicts risk categories in patients with cirrhosis, PANDORA study
Authors: Jorge Poo, José Raúl Izaguirre, Frida Gasca-Díaz, Juan Ramón Aguilar, Carlos Ramírez-Castillo, Javier Lizardi, Juan Francisco Rivera-Ramos, Juan Alfredo Tamayo, Carina Zapata, Carolina Treviño-Garcia, Miroslava Hernández, Ilsa López, Graciela Tapia, Paula Cordero-Pérez, Linda Elsa Muñoz-Espinosa
Journal: Journal of Hepatology (2024)
WED-195 NASH-PI: a randomized trial to compare cost-effectiveness across strategies for screening, referring and management of MASLD patients in clinical practice
Authors: Manuel Romero-Gómez, Florencia Pollarsky, Silvia Garcia Rey, Rocío Gallego-Durán, Vanessa García-Fernández, Isabel Fernández-Lizaranzu, Francisco Javier Atienza Martín, Pablo Remon, Carmen Lara-Romero, María C. Roque-Cuéllar, Inmaculada Dominguez, Yolanda María Sanchez-Torrijos, Ioanna-Panagiota Kalafati, Sabine Kahl, Michael Roden, Pedro Pablo García-Luna, Jörn Schattenberg, George Dedoussis, Davide Fortin, Abbas Mourad, Patrizia Carrieri, Patrizia Marino, Jeffrey V. Lazarus
Journal: Journal of Hepatology (2024)
TOP-488-YI Fecal microbiota transplant combined with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma who progressed on atezolizumab plus bevacizumab-interim analysis of the FAB-HCC phase II pilot study
Authors: Katharina Pomej, Adrian Frick, Bernhard Scheiner, Lorenz Balcar, Larissa Pajancic, Anton Klotz, Katharina Regnat, Kerstin Zinober, Michael Trauner, Dietmar Tamandl, Christoph Gasche, Matthias Pinter
Journal: Journal of Hepatology (2024)
WED-220 BOS-580, a long-acting FGF-21 analogue, treatment shows beneficial changes in the circulating lipidome and improves MASEF score in patients with phenotypic metabolic dysfunction-associated steatohepatitis in a phase 2a randomized, placebo-controlled, 12-week study
Authors: Gerard Bain, Alicia Clawson, Juan Carlos Lopez-Talavera, Tatjana Odrljin
Journal: Journal of Hepatology (2024)
FRI-194-YI Risk of all-cause mortality and adverse outcomes from steatotic liver disease and its subgroups in the general population
Authors: Maurice Michel, Angelo Armandi, Alexander Gieswinkel, Alexander Schuster, Thomas Muenzel, Stavros Konstantinides, Matthias Michal, Beate Straub, Irene Schmidtmann, Oliver Tuescher, Philipp Wild, Karl Lackner, Peter R. Galle, Jörn M Schattenberg
Journal: Journal of Hepatology (2024)
WED-236-YI Real world evaluation of a primary care pathway for the assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)
Authors: Basil Ahmad, Oliver Mitchell, Sally Pannifex, Arjuna Singanayagam, Sarah Hughes, Sarah Clark, Metin Yalcin, Nicola Williams, Sarah Davie, Daniel Forton
Journal: Journal of Hepatology (2024)